Leerink Partners Issues Positive Forecast for Ardent Health Partners (NYSE:ARDT) Stock Price

Ardent Health Partners (NYSE:ARDTGet Free Report) had its target price raised by Leerink Partners from $23.00 to $25.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Leerink Partners’ price objective indicates a potential upside of 44.93% from the stock’s previous close.

Several other research firms have also recently commented on ARDT. Mizuho assumed coverage on Ardent Health Partners in a research note on Monday, August 12th. They issued an “outperform” rating and a $20.00 target price for the company. Loop Capital began coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set a “buy” rating and a $18.00 price target for the company. Royal Bank of Canada initiated coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They issued an “outperform” rating and a $23.00 price objective on the stock. Bank of America downgraded Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their price target for the company from $22.00 to $19.00 in a research note on Wednesday, November 6th. Finally, Morgan Stanley assumed coverage on Ardent Health Partners in a research note on Monday, August 12th. They set an “overweight” rating and a $27.00 price objective for the company. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $21.82.

Get Our Latest Stock Analysis on ARDT

Ardent Health Partners Price Performance

Shares of ARDT opened at $17.25 on Tuesday. The company has a quick ratio of 1.54, a current ratio of 1.65 and a debt-to-equity ratio of 0.93. Ardent Health Partners has a 1 year low of $14.57 and a 1 year high of $20.72. The stock has a 50 day moving average of $18.42.

Ardent Health Partners (NYSE:ARDTGet Free Report) last issued its earnings results on Wednesday, August 14th. The company reported $0.35 EPS for the quarter, beating the consensus estimate of $0.30 by $0.05. The firm had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. As a group, research analysts forecast that Ardent Health Partners will post 1.28 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of ARDT. Allspring Global Investments Holdings LLC acquired a new stake in Ardent Health Partners in the third quarter valued at about $13,119,000. Seven Grand Managers LLC bought a new position in Ardent Health Partners in the 3rd quarter valued at approximately $2,298,000. Finally, Financial Management Professionals Inc. acquired a new stake in Ardent Health Partners in the third quarter valued at approximately $50,000.

About Ardent Health Partners

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Further Reading

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.